{"transactions":[{"id":728555,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:26:45.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Company Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. The reporting person has elected to defer the receipt of Common Stock upon the vesting of their RSUs pursuant to the Company's Non-Employee Director Compensation Policy until earlier of (i)  30 days following separation from continuous service with the company and (ii) a change in control of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Company Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. The reporting person has elected to defer the receipt of Common Stock upon the vesting of their RSUs pursuant to the Company's Non-Employee Director Compensation Policy until earlier of (i)  30 days following separation from continuous service with the company and (ii) a change in control of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Company Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. The reporting person has elected to defer the receipt of Common Stock upon the vesting of their RSUs pursuant to the Company's Non-Employee Director Compensation Policy until earlier of (i)  30 days following separation from continuous service with the company and (ii) a change in control of the Company."}],"balance_after":95400,"derivative":{"underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001764157-26-000004","document":"wk-form4_1782246402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000176415726000004/wk-form4_1782246402.xml","form_type":"4"}},{"id":893349,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T15:46:23.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":153195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":153195,"derivative":{"underlying":"Ordinary Shares","underlying_shares":153195},"source":{"system":"sec-edgar","filing":"0001437749-26-004638","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926004638/rdgdoc.xml","form_type":"4"}},{"id":1078141,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-31T11:48:57.000Z","date":"2025-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Shares (a \"Company Option\") then outstanding and unexercised, whether or not vested, which had a per Share exercise price less than the Closing Amount was deemed fully vested and cancelled and converted into the right to receive (i) a cash payment (without interest and subject to the withholding of applicable taxes) equal to the product of (a) the excess of the Closing Amount over the per Share exercise price of such Company Option, multiplied by (b) the total number of Shares subject to such Company Option immediately prior to the Effective Time, plus (ii) one CVR for each Share subject to such Company Option immediately prior to the Effective Time. Each Company Option, whether or not vested, which had a per Share exercise price greater than or equal to the Closing Amount was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Shares (a \"Company Option\") then outstanding and unexercised, whether or not vested, which had a per Share exercise price less than the Closing Amount was deemed fully vested and cancelled and converted into the right to receive (i) a cash payment (without interest and subject to the withholding of applicable taxes) equal to the product of (a) the excess of the Closing Amount over the per Share exercise price of such Company Option, multiplied by (b) the total number of Shares subject to such Company Option immediately prior to the Effective Time, plus (ii) one CVR for each Share subject to such Company Option immediately prior to the Effective Time. Each Company Option, whether or not vested, which had a per Share exercise price greater than or equal to the Closing Amount was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":6.77,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0000950170-25-100675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000095017025100675/ownership.xml","form_type":"4"}},{"id":1078140,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T11:48:57.000Z","date":"2025-07-31","kind":"other","planned":false,"acquired":false,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 13, 2025, among Sage Therapeutics, Inc. (the \"Issuer\"), Supernus Pharmaceuticals, Inc. (\"Parent\"), and Saphire, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a cash tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of July 31, 2025 (the effective time of the merger, the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $8.50 per Share in cash (the \"Closing Amount\"), plus (ii) one contingent value right (\"CVR\") per Share, each without interest and subject to the withholding of applicable taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Each CVR represents the right to receive up to $3.50 per Share in cash upon the satisfaction of specified milestones, as described in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 13, 2025, among Sage Therapeutics, Inc. (the \"Issuer\"), Supernus Pharmaceuticals, Inc. (\"Parent\"), and Saphire, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a cash tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of July 31, 2025 (the effective time of the merger, the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $8.50 per Share in cash (the \"Closing Amount\"), plus (ii) one contingent value right (\"CVR\") per Share, each without interest and subject to the withholding of applicable taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Each CVR represents the right to receive up to $3.50 per Share in cash upon the satisfaction of specified milestones, as described in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on June 16, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-100675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000095017025100675/ownership.xml","form_type":"4"}},{"id":1079098,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2025-07-30T20:08:22.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":87615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance stock units (\"PSUs\") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance stock units (\"PSUs\") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares."}],"balance_after":87615,"derivative":{"underlying":"Ordinary Shares","underlying_shares":87615},"source":{"system":"sec-edgar","filing":"0001437749-25-023969","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023969/rdgdoc.xml","form_type":"4"}},{"id":1103409,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-24T01:03:34.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Barrett has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Barrett has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Barrett has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."}],"balance_after":95400,"derivative":{"underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001737287-25-000074","document":"wk-form4_1750727007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000074/wk-form4_1750727007.xml","form_type":"4"}},{"id":1111015,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:13:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 11, 2026 or the day immediately prior to the 2026 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":21500,"derivative":{"exercise_price":6.77,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001562180-25-004787","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597553/000156218025004787/primarydocument.xml","form_type":"4"}},{"id":1284820,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:49:08.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":96377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."}],"balance_after":96377,"derivative":{"underlying":"Ordinary Shares","underlying_shares":96377},"source":{"system":"sec-edgar","filing":"0001437749-25-002683","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002683/rdgdoc.xml","form_type":"4"}},{"id":1486044,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-07T21:34:50.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":191082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments"}],"balance_after":191082,"derivative":{"exercise_price":2.44,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":191082},"source":{"system":"sec-edgar","filing":"0001593968-24-000840","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396824000840/primary_01.xml","form_type":"4"}},{"id":1661715,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:04:22.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":87615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."}],"balance_after":87615,"derivative":{"underlying":"Ordinary Shares","underlying_shares":87615},"source":{"system":"sec-edgar","filing":"0001437749-24-003012","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003012/rdgdoc.xml","form_type":"4"}},{"id":1853760,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T21:03:17.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":116120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments"}],"balance_after":116120,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":116120},"source":{"system":"sec-edgar","filing":"0001593968-23-001012","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396823001012/primary_01.xml","form_type":"4"}},{"id":2036149,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"date","element":"transactionDate","label":"F8","text":"The performance stock units were approved by the Board of Directors of the Issuer on January 31, 2023. If the performance stock units are not ratified by the Issuer's shareholders at the Issuer's 2023 annual general meeting, the performance stock units will terminate."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All shares underlying the performance stock units will vest upon achievement of a corporate milestone event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"All shares underlying the performance stock units will vest upon achievement of a corporate milestone event."}],"balance_after":100000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036148,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":125000,"derivative":{"exercise_price":10.39,"expiration_date":"2033-01-31","underlying":"Ordinary Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036147,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":75000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036146,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022."}],"balance_after":13334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036145,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036144,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":326691,"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2036143,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-02T20:40:58.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":313358,"source":{"system":"sec-edgar","filing":"0001437749-23-002358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002358/rdgdoc.xml","form_type":"4"}},{"id":2226480,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:57:39.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":71070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments."}],"balance_after":71070,"derivative":{"exercise_price":9.62,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":71070},"source":{"system":"sec-edgar","filing":"0001214659-22-008168","document":"marketforms-56493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465922008168/marketforms-56493.xml","form_type":"4"}},{"id":2416695,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025"}],"balance_after":150000,"derivative":{"exercise_price":7.72,"expiration_date":"2032-01-31","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416694,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"exercise","acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022."}],"balance_after":26667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416693,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021."}],"balance_after":5000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416692,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"sale","acquired":false,"shares":5960,"price":7.58,"value":45176.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":308358,"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416691,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"exercise","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":314318,"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416690,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"sale","acquired":false,"shares":2235,"price":7.58,"value":16941.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":300985,"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2416689,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:32:42.000Z","date":"2022-01-31","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":303220,"source":{"system":"sec-edgar","filing":"0001209191-22-006383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006383/doc4.xml","form_type":"4"}},{"id":2440034,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-07T13:38:53.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":105689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs vested on January 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs vested on January 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":105689},"source":{"system":"sec-edgar","filing":"0001209191-22-002305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122002305/doc4.xml","form_type":"4"}},{"id":2440033,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-07T13:38:53.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":46968,"price":9.15,"value":429757.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":298220,"source":{"system":"sec-edgar","filing":"0001209191-22-002305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122002305/doc4.xml","form_type":"4"}},{"id":2440032,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-07T13:38:53.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":105689,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":345188,"source":{"system":"sec-edgar","filing":"0001209191-22-002305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122002305/doc4.xml","form_type":"4"}},{"id":2616657,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-03T21:32:38.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":63385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in a series of 36 successive equal monthly installments measured from the date of grant."}],"balance_after":63385,"derivative":{"exercise_price":21.95,"expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":63385},"source":{"system":"sec-edgar","filing":"0001214659-21-008123","document":"marketforms-53498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000121465921008123/marketforms-53498.xml","form_type":"4"}},{"id":2636151,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":8808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":114496,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8808},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636150,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":8808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":123304,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8808},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636149,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-10-03","kind":"exercise","acquired":false,"shares":8808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":132112,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8808},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636148,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-09-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":140920,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636147,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":149727,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636146,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-07-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":158534,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636145,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:59:39.000Z","date":"2020-06-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":167341,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636144,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":8808,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":219117,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636143,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":8808,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":210309,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636142,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-10-03","kind":"exercise","acquired":true,"shares":8808,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":201501,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636141,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-09-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":192693,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636140,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":183886,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636139,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-07-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":175079,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636138,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:59:39.000Z","date":"2020-06-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020.  In fact, the shares vested monthly from June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":166272,"source":{"system":"sec-edgar","filing":"0001209191-21-046344","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046344/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-04"}},{"id":2636137,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:57:46.000Z","date":"2020-05-03","kind":"exercise","acquired":false,"shares":8808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":176148,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8808},"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636136,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:57:46.000Z","date":"2020-04-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":198956,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636135,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:57:46.000Z","date":"2020-03-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":193763,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636134,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T22:57:46.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2019, the reporting person was granted restricted stock units (\"RSUs\") representing 317,065 ordinary shares.  1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years."}],"balance_after":202570,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636133,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:57:46.000Z","date":"2020-05-03","kind":"exercise","acquired":true,"shares":8808,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":157465,"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636132,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:57:46.000Z","date":"2020-04-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":148657,"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636131,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:57:46.000Z","date":"2020-03-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":139850,"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2636130,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-12T22:57:46.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020.  In fact, the shares vested monthly from February 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":131043,"source":{"system":"sec-edgar","filing":"0001209191-21-046340","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121046340/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-14"}},{"id":2700923,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-21T17:44:58.000Z","date":"2021-01-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021."}],"balance_after":10000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2700922,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-21T17:44:58.000Z","date":"2021-01-03","kind":"exercise","acquired":false,"shares":8807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020.  33.33% of the RSUs vested in equal monthly installments through January 3, 2021.  The remaining 33.33% of the RSUs will vest on January 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020.  33.33% of the RSUs vested in equal monthly installments through January 3, 2021.  The remaining 33.33% of the RSUs will vest on January 3, 2022."}],"balance_after":105689,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8807},"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2700921,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-21T17:44:58.000Z","date":"2021-05-19","kind":"tax_withholding","acquired":false,"shares":1240,"price":17.5089,"value":21711.036,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs."}],"balance_after":239499,"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2700920,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-21T17:44:58.000Z","date":"2021-05-19","kind":"tax_withholding","acquired":false,"shares":2185,"price":17.5089,"value":38256.9465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs."}],"balance_after":240739,"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2700919,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-21T17:44:58.000Z","date":"2021-01-31","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":242924,"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2700918,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-21T17:44:58.000Z","date":"2021-01-03","kind":"exercise","acquired":true,"shares":8807,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":237924,"source":{"system":"sec-edgar","filing":"0001209191-21-034823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121034823/doc4.xml","form_type":"4"}},{"id":2885716,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-02T19:54:20.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024"}],"balance_after":40000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-006700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121006700/doc4.xml","form_type":"4"}},{"id":2885715,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-02T19:54:20.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024"}],"balance_after":150000,"derivative":{"exercise_price":22.07,"expiration_date":"2031-01-31","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-006700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121006700/doc4.xml","form_type":"4"}},{"id":2944501,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-15T22:27:35.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":10000,"price":18.5,"value":185000.0,"ownership":{"direct":true},"balance_after":229117,"source":{"system":"sec-edgar","filing":"0001209191-20-063558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120063558/doc4.xml","form_type":"4"}},{"id":2956628,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-12-04T21:35:16.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":61652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."}],"balance_after":114496,"derivative":{"underlying":"Ordinary Shares","underlying_shares":61652},"source":{"system":"sec-edgar","filing":"0001209191-20-061812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120061812/doc4.xml","form_type":"4"}},{"id":2956627,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-12-04T21:35:16.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":61652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the settlement of restricted stock units that vested from June 3, 2020 through December 3, 2020 through the issuance of ordinary shares."}],"balance_after":219117,"source":{"system":"sec-edgar","filing":"0001209191-20-061812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120061812/doc4.xml","form_type":"4"}},{"id":3149016,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-14T17:07:11.000Z","date":"2020-05-12","kind":"exercise","acquired":false,"shares":35229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 3, 2019 representing 317,065 ordinary shares.  33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on January 3, 2019 representing 317,065 ordinary shares.  33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."}],"balance_after":176148,"derivative":{"underlying":"Ordinary Shares","underlying_shares":35229},"source":{"system":"sec-edgar","filing":"0001209191-20-029079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120029079/doc4.xml","form_type":"4"}},{"id":3149015,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-14T17:07:11.000Z","date":"2020-05-12","kind":"exercise","acquired":true,"shares":35229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the settlement of restricted stock units that vested from February 3, 2020 through May 3, 2020 through the issuance of ordinary shares."}],"balance_after":157465,"source":{"system":"sec-edgar","filing":"0001209191-20-029079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120029079/doc4.xml","form_type":"4"}},{"id":3291813,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-04T17:36:47.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":15000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-006208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120006208/doc4.xml","form_type":"4"}},{"id":3291812,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2020-02-04T17:36:47.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":45000,"derivative":{"exercise_price":29.41,"underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-006208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120006208/doc4.xml","form_type":"4"}},{"id":3316434,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T23:30:47.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":105688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2018, the reporting person was granted 317,065 restricted stock units of which 33% vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2018, the reporting person was granted 317,065 restricted stock units of which 33% vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter."}],"balance_after":211377,"derivative":{"underlying":"Ordinary Shares","underlying_shares":105688},"source":{"system":"sec-edgar","filing":"0001209191-20-002366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120002366/doc4.xml","form_type":"4"}},{"id":3316433,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T23:30:47.000Z","date":"2020-01-03","kind":"exercise","acquired":true,"shares":105688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the settlement of restricted stock units that vested on January 3, 2020 through the issuance of ordinary shares."}],"balance_after":122236,"source":{"system":"sec-edgar","filing":"0001209191-20-002366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120002366/doc4.xml","form_type":"4"}},{"id":3361227,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-22T20:34:37.000Z","date":"2019-11-21","kind":"purchase","acquired":true,"shares":7530,"price":28,"value":210840.0,"ownership":{"direct":true},"balance_after":16548,"source":{"system":"sec-edgar","filing":"0001209191-19-057766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119057766/doc4.xml","form_type":"4"}},{"id":3361226,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-22T18:35:28.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":7470,"price":28,"value":209160.0,"ownership":{"direct":true},"balance_after":9018,"source":{"system":"sec-edgar","filing":"0001209191-19-057755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119057755/doc4.xml","form_type":"4"}},{"id":3368348,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-19T00:32:26.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":1548,"price":26,"value":40248.0,"ownership":{"direct":true},"balance_after":1548,"source":{"system":"sec-edgar","filing":"0001209191-19-057044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119057044/doc4.xml","form_type":"4"}},{"id":3699092,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-01-10T01:25:08.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":317065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33% of the RSUs will vest on January 3, 2020 and the remaining RSUs will vest 2.778% in equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"33% of the RSUs will vest on January 3, 2020 and the remaining RSUs will vest 2.778% in equal monthly installments thereafter."}],"balance_after":317065,"derivative":{"underlying":"Ordinary Shares","underlying_shares":317065},"source":{"system":"sec-edgar","filing":"0001209191-19-003174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119003174/doc4.xml","form_type":"4"}},{"id":3699091,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":35887,"kind":"person","name":"Barrett Elizabeth A.","position":1,"cik":"0001764157","reported_name":"Barrett Elizabeth A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-10T01:25:08.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":277432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying the stock option will vest on January 3, 2020 and 2.778% of the remaining shares will vest in equal monthly installments thereafter."}],"balance_after":277432,"derivative":{"exercise_price":47.57,"expiration_date":"2029-01-03","underlying":"Ordinary Shares","underlying_shares":277432},"source":{"system":"sec-edgar","filing":"0001209191-19-003174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119003174/doc4.xml","form_type":"4"}}]}